Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2012-11-19

Clinical Trial Update: Pharmacokinetics Study of Dapsone-Adapalene Fixed Combination Gel in Acne [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of a dapsone-adapalene fixed combination gel for acne was withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Adapalene (Adapalene)
  • DAPSONE (dapsone)

Snippet

Sponsor: Allergan | Conditions: Acne Vulgaris | Phase 1 | Status: WITHDRAWN